Articles tagged "Kidney transplantation"

2020 American Transplant Congress
Single Center Kidney Costs and Transplant Outcomes Analysis of Undocumented Aliens
Y. A. Qazi, E. Villalon, T. Sadiq, E. Qazi, E. Mir, A. Reza, M. Smogorzewski
USC, Los Angeles, CA
*Purpose: The purpose of the study was to perform an outcomes and cost comparison analysis between dialysis and kidney transplantation in individuals identified as undocumented…
2020 American Transplant Congress
Assessing Providers’ Accuracy in Predicting Early Readmission after Kidney and Liver Transplantation
K. Maroney, Z. Wang, R. Lynch, A. Adams, R. Patzer, J. Hogan
Emory University, Atlanta, GA
*Purpose: Predictive models capable of identifying patients at risk for readmission are in development. However, it is unknown how accurate clinicians are at predicting early…
2020 American Transplant Congress
Robotic Donor Nephrectomy: A Novel Approach to Improve Living Donor Kidney Transplantation
R. Shahbazov¹, A. Popovic¹, D. Friedman², I. Bandler², S. Loerzel¹, K. Heslin², R. Hod Duvarai³, B. Gallay⁴, O. Pankewycz⁴, M. Laftavi¹
¹Surgery, Upstate Medical University, Syracuse, NY, ²College of Medicine, Upstate Medical University, Syracuse, NY, ³Pathology, Upstate Medical University, Syracuse, NY, ⁴Medicine, Upstate Medical University, Syracuse, NY
*Purpose: Robotic assisted live donor nephrectomies (RDN) have continued to gain popularity in recent years. Our purpose was to investigate the difference in outcomes between…
2020 American Transplant Congress
The UCSF Cardiovascular Risk after Kidney Transplantation (CARAKTER) Study
M. Park¹, Y. Gao¹, S. Schroeder², S. Siyahian¹, Z. Laszik¹, F. Vincenti¹
¹UCSF, San Francisco, CA, ²UC Davis, Sacramento, CA
*Purpose: We established the UCSF CARAKTER (Cardiovascular Risk After Kidney Transplantation) Study in order to evaluate risk factors for cardiac disease onset and progression in…
2020 American Transplant Congress
Impact of Timing of T Cell Mediated Rejection in the First Year after Kidney Transplantation
R. Mehta, D. Jorgensen, C. Puttarajappa, S. Hariharan, R. Mehta, P. Sood
University of Pittsburgh Medical Center, Pittsburgh, PA
*Purpose: To evaluate the impact of timing of T-cell mediated rejection (TCMR) occurrence in the first year after kidney transplantation (KT).*Methods: Single center retrospective cohort…
2020 American Transplant Congress
Renal Transplantation Into Urinary Diversions and Reconstructed Bladders
J. J. Chong, R. H. Zakri, S. Khan, G. Koffman, N. Mamode, J. Olsburgh
Guy's Hospital, London, United Kingdom
*Purpose: Renal failure secondary to urological disorders can necessitate urinary diversion or reconstruction either pre or post-kidney transplant. Decision making regarding timing of diversion or…
2020 American Transplant Congress
Characteristics of Kidney Transplant Patients Diagnosed with Histoplasmosis
C. Miles, J. Hall, S. Westphal, E. Langewisch
University of Nebraska Medical Center, Omaha, NE
*Purpose: Histoplasmosis is responsible for the greatest number of hospitalizations and deaths due to endemic mycoses in the United States. Although lying near the western…
2020 American Transplant Congress
High Health Literacy is Associated with Decreased Likelihood of Waitlist Mortality for Some Solid Organ Transplant Candidates
L. Dageforde¹, S. Rega², I. Feurer³
¹Massachusetts General Hospital, Boston, MA, ²Vanderbilt Transplant Center, Nashville, TN, ³Department of Surgery, Vanderbilt Transplant Center, Vanderbilt University Medical Center, Nashville, TN
*Purpose: Health Literacy (HL) impacts post-transplant outcomes and listing for kidney transplant patients, but little is known about likelihood of solid organ transplant for kidney…
2020 American Transplant Congress
Utility of dd-cfDNA in TCMR 1A and Borderline Allograft Rejection
E. Stites¹, D. Kumar², O. Olaitan³, G. Gupta²
¹University of Colorado, Aurora, CA, ²Virginia Commonwealth University, Richmond, VA, ³Rush University, Chicago, CA
*Purpose: The value of donor-derived cell-free DNA (dd-cfDNA, AlloSure) as a molecular marker for the early diagnosis of mild T-cell mediated rejection (Banff TCMR 1A…
2020 American Transplant Congress
Recipient LAG3 Deficiency Results in Antibody-Mediated Rejection of Mouse Renal Allografts
M. Nicosia, R. Fan, J. Lee, V. Gorbacheva, A. Beavers, N. Dvorina, W. M. Baldwin III, R. L. Fairchild, B. Min, A. Valujskikh
Inflammation and Immunity, Cleveland Clinic, Cleveland, OH
*Purpose: Lymphocyte activation gene-3 (LAG3) is a coinhibitory receptor on the surface of T and B lymphocytes, NK cells and plasmacytoid dendritic cells. Its functions…